FDA Indications and BMI Requirements Tirzepatide is FDA approved as Mounjaro for adults with type 2 diabetes and as Zepbound for adults with chronic weight management when BMI is 30 kg/m or 27 kg/m with a weight-related condition (e.g., hypertension, dyslipidemia, T2D, OSA, CVD)
It is important to be consistent, as it often takes 8 to 12 weeks of daily use to see visible improvements in skin texture
Animal studies have shown it could be harmful to a developing baby, and there isnt enough human data yet to prove its safe
Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM et al
While BPC-157 primarily focuses on repairing the gut lining, muscles, and connective tissues, TB-500 complements it by improving cellular communication and promoting new blood vessel growth together creating a synergistic healing effect that extends across multiple systems in the body